Closed Protocol
Resources for Members
Clinical Trials
Files with the extension 'zip' require the Winzip application to open.
03-293
GOG 146O - A PHASE II EVALUATION OF IROFULVEN (IND#55804, NSC#683863) IN THE TREATMENT OF RECURRENT OR PERSISTENT PLATINUM-SENSITIVE OVARIAN OR PRIMARY PERITONEAL CANCER more details
|
|
| |
02-120
GOG 173 - INTRAOPERATIVE LYMPHATIC MAPPING AND SENTINEL NODE (SN) IDENTIFICATION IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE VULVA more details
|
|
| |
02-190
GOG 181B - A PHASE II EVALUATION OF TRASTUZUMAB (NSC #688097 [MoAb HER2]) IN PATIENTS WITH ADVANCED, RECURRENT OR PERSISTENT ENDOMETRIAL CARCINOMA WITH OR WITHOUT PRIOR CHEMOTHERAPY more details
|
|
| |
02-230
GOG 198 - A RANDOMIZED STUDY OF TAMOXIFEN VERSUS THALIDOMIDE (NSC# 66847) IN PATIENTS WITH BIOCHEMICAL RECURRENCE ONLY EPITHELIAL OVARIAN CANCER, CANCER OF THE FALLOPIAN TUBE, AND PRIMARY PERITONEAL CARCINOMA AFTER FIRST LINE CHEMOTHERAPY more details
|
|
| |
03-250
GOG 209 - A RANDOMIZED PHASE III TRIAL OF DOXORUBICIN/CISPLATIN/PACLITAXEL/G-CSF VERSUS CARBOPLATIN/PACLITAXEL IN PATIENTS WITH STAGE III & IV OR RECURRENT ENDOMETRIAL CANCER more details
|
|
| |
03-297
GOG 210 - A MOLECULAR STAGING STUDY OF ENDOMETRIAL CANCER more details
|
|
| |
05-403
A MULTICENTER PHASE III TRIAL OF PATUPILONE VERSUS DOXIL IN TAXANE/PLATINUM REFRACTORY/RESISTANT PATIENTS WITH RECURRENT EPITHELIAL OVARIAN, PRIMARY FALLOPIAN OR PRIMARY PERITONEAL CANCER more details
Protocol
Consent Form
|
|
| |
|